The 4 most recent market catalysts affecting $NAUT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 11, 2026
Corporate Catalyst
Neutral
Impact 65
Nautilus Biotechnology Files $300M Shelf Registration, Including $125M Nasdaq Common Stock ATM Offering Through TD Cowen
Nautilus Biotechnology filed an S-3 shelf registration statement, allowing them to offer and sell up to $300 million in various securities over time. Crucially, this includes a $12…
Sep 9, 2026
Corporate Catalyst
Bullish
Impact 75
Nautilus Biotechnology shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $4 price target.
The initiation of coverage by a reputable firm like Leerink Partners with an 'Outperform' rating is a significant positive catalyst for Nautilus Biotechnology. It signals to the ma…
Sep 9, 2026
Corporate Catalyst
Neutral
Impact 55
Leerink Partners Initiates Coverage On Nautilus Biotechnology with Outperform Rating, Announces Price Target of $4
Leerink Partners initiating coverage on Nautilus Biotechnology with an Outperform rating and a $4 price target is a positive development for the company. Analyst coverage can incre…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 55
Amazon Sold Holding In Nautilus Biotechnology
This headline indicates Amazon's decision to sell its holding in Nautilus Biotechnology. For Amazon, this is likely a minor portfolio adjustment with negligible impact on its overa…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.